Wedge Capital Management’s PetMed Express PETS Stock Holding History

Wedge Capital Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,082	Closed	-$445K	–	586
2020 Q3	$445K	Hold	14,082	–	–	0.01%	389
2020 Q2	$502K	Sell	14,082 -17,270	-55%	-$600K	0.01%	360
2020 Q1	$902K	Buy	+31,352	New	+$822K	0.02%	299

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Wedge Capital Management's PETS Position: Q4 2020 in Review

Wedge Capital Management sold out of PetMed Express (PETS) in Q4 2020, closing a stake of 14,082 shares — an estimated $445K sold.

Wedge Capital Management first reported a position in PETS in Q1 2020 and held it in 3 quarters. The position peaked at $902K in Q1 2020. 213 funds tracked by Wall St. Rank hold PETS as of Q4 2020.

Wedge Capital Management reported no remaining PetMed Express position as of Q4 2020 after selling out during the quarter.
Wedge Capital Management sold 14,082 PetMed Express shares in Q4 2020, an estimated $445K.
Wedge Capital Management first reported a position in PetMed Express in Q1 2020 and held it in 3 quarters.
Wedge Capital Management's PetMed Express position peaked at $902K in Q1 2020.
213 funds tracked by Wall St. Rank held PetMed Express as of Q4 2020.

Based on Wedge Capital Management's 13F filing for Q4 2020, filed 8 Jan 2021.